Innovations

Found results: 1005

Innovative Russia

"Biopharmaceutical Nobel Prize" – to Russian scientists

The winners of the Galen Prize in 2013 were A.Sobolev and A.Rosenkrantz from the Institute of Gene Biology of the Russian Academy of Sciences, as well as V.Lunin from the Research Institute of Epidemiology and Microbiology.Gamalei. Their development will allow thousands of times to increase the effectiveness of drugs and, above all, in oncology.

07.11.2013
Biotechnologies - into life

Breast milk will help cure cancer

Preclinical trials of an antitumor drug based on lactaptin, one of the proteins of breast milk, have been completed in Novosibirsk.

30.10.2013
Innovative Russia

Skolkovo was caught in sawing and kickbacks

The Prosecutor General's Office of the Russian Federation implements a set of measures to compensate for damage and eliminate violations of the law during the implementation of the project to create the Skolkovo Innovation Center.

30.10.2013
Note to the businessman

Top 10 Biotech companies that went public in 2013

Nowhere does the old Latin definition of “caveat emptor” (buyer, bdi) better illustrate the situation than in the biotech sector. This year, the revenues were very large. The risks were the same.

25.10.2013
Innovative Russia

A hybrid of a pan with a fan

Vortex bioreactors are very simple at first glance. And they are also very cheap and allow you to reduce energy costs for production by five to ten times.

25.10.2013
Biotechnologies - into life

Biopharmaceuticals in Russia

Corresponding Member of the Russian Academy of Sciences Alexander Gabibov - about how biotechnologies and pharmaceuticals are developing in Russia.

17.10.2013
Biotechnologies - into life

Novosibirsk against cancer: details

Novosibirsk innovative company has successfully completed preclinical trials of a therapeutic vaccine against breast cancer. After 2-3 years, a new method of treating cancer can be put into practice.

10.10.2013
Innovative Russia

Novosibirsk against cancer: two good news

The developer of the breast cancer vaccine "AquasisBio" is preparing to conduct clinical trials, and the "Dendritic Cell Laboratory" is preparing to create a center for cell therapy of oncological diseases.

02.10.2013
Note to the businessman

How Two Doctors earned more than $1 billion on Mutations

The creators of Regeneron Pharmaceuticals use mutations in the genes of the human body to develop pharmaceuticals. As a result, Schleifer is about to become a billionaire, and Yankopoulos' fortune is estimated at $ 400 million.

02.10.2013
Note to the businessman

Bad news from the Russian venture capital market

The total volume of venture transactions in Russia in the 2nd quarter of 2013 amounted to 87 million US dollars, showing a decrease of 41.3% compared to the 1st quarter of 2013 and 47.7% compared to the 2nd quarter. The number of transactions also dropped sharply.

20.09.2013
Innovative Russia

Investors have tripled their investments in Skolkovo

The amount of investments in the Skolkovo project received by participating companies from accredited investors has tripled in eight months of this year to 1.126 billion rubles, said Viktor Vekselberg, president of the Skolkovo Foundation.

19.09.2013
Biotechnologies - into life

Russian drugs will be no worse and cheaper than imported ones

The first three domestic drugs based on monoclonal antibodies, which will treat cancer of the blood, lymph nodes, mammary glands and lungs, will go on sale next year. Their price will be 30% lower than imported ones.

09.09.2013
Innovative Russia

Open Innovations – 2013: work program

Within the framework of the global discussion platform "Open Innovations", discussions, round tables and master classes dedicated to the latest achievements in the field of technological innovation will take place.

29.08.2013
Innovative Russia

Man in the palm of your hand

The box is smaller than a mobile phone – a model of human organs in one millionth of magnitude. Human organs and tissues are much more complicated, but today this development allows us to create, perhaps, their most adequate model.

12.07.2013
Biotechnologies - into life

Made in Zelenograd

NIOBIS company became one of the first startups of the Zelenograd Nanocenter, and today its project in the field of electrostimulation of cell growth on nanostructured surfaces is preparing to find serious investors.

09.07.2013